200 related articles for article (PubMed ID: 27249080)
1. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial.
Rodgman C; Verrico CD; Holst M; Thompson-Lake D; Haile CN; De La Garza R; Raskind MA; Newton TF
J Clin Psychiatry; 2016 May; 77(5):e561-5. PubMed ID: 27249080
[TBL] [Abstract][Full Text] [Related]
2. A Double-Blind Randomized Controlled Trial of Doxazosin for Co-Occurring PTSD and Alcohol Use Disorder in Veterans.
Back SE; Flanagan JC; Mintz J; Brady KT; Jones J; Jarnecke AM; Joseph JE; Shirley DW; Malcolm RJ; Hamner M; Litz BT; Niles BL; Young-McCaughan S; Keane TM; Peterson AL
J Clin Psychiatry; 2023 Mar; 84(2):. PubMed ID: 36883885
[No Abstract] [Full Text] [Related]
3. Alcohol Abstainer Status and Prazosin Treatment in Association with Changes in Posttraumatic Stress Disorder Symptoms in Veterans with Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder.
Verplaetse TL; Ralevski E; Roberts W; Gueorguieva R; McKee SA; Petrakis IL
Alcohol Clin Exp Res; 2019 Apr; 43(4):741-746. PubMed ID: 30698839
[TBL] [Abstract][Full Text] [Related]
4. Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart Review.
Roepke S; Danker-Hopfe H; Repantis D; Behnia B; Bernard F; Hansen ML; Otte C
Pharmacopsychiatry; 2017 Jan; 50(1):26-31. PubMed ID: 27276365
[No Abstract] [Full Text] [Related]
5. Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the Veterans Affairs cooperative study #504.
Krystal JH; Pietrzak RH; Rosenheck RA; Cramer JA; Vessicchio J; Jones KM; Huang GD; Vertrees JE; Collins J; Krystal AD;
J Clin Psychiatry; 2016 Apr; 77(4):483-91. PubMed ID: 26890894
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial.
Krystal JH; Rosenheck RA; Cramer JA; Vessicchio JC; Jones KM; Vertrees JE; Horney RA; Huang GD; Stock C;
JAMA; 2011 Aug; 306(5):493-502. PubMed ID: 21813427
[TBL] [Abstract][Full Text] [Related]
7. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.
Raskind MA; Thompson C; Petrie EC; Dobie DJ; Rein RJ; Hoff DJ; McFall ME; Peskind ER
J Clin Psychiatry; 2002 Jul; 63(7):565-8. PubMed ID: 12143911
[TBL] [Abstract][Full Text] [Related]
8. Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans.
Back SE; Flanagan JC; Jones JL; Augur I; Peterson AL; Young-McCaughan S; Shirley DW; Henschel A; Joseph JE; Litz BT; Hancock AK; Roache JD; Mintz J; Wachen JS; Keane TM; Brady KT;
Contemp Clin Trials; 2018 Oct; 73():8-15. PubMed ID: 30145268
[TBL] [Abstract][Full Text] [Related]
9. Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms.
Spangler PT; West JC; Dempsey CL; Possemato K; Bartolanzo D; Aliaga P; Zarate C; Vythilingam M; Benedek DM
J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33113596
[TBL] [Abstract][Full Text] [Related]
10. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment.
Naylor JC; Kilts JD; Bradford DW; Strauss JL; Capehart BP; Szabo ST; Smith KD; Dunn CE; Conner KM; Davidson JR; Wagner HR; Hamer RM; Marx CE
Int Clin Psychopharmacol; 2015 May; 30(3):167-74. PubMed ID: 25647451
[TBL] [Abstract][Full Text] [Related]
11. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.
Raskind MA; Peskind ER; Kanter ED; Petrie EC; Radant A; Thompson CE; Dobie DJ; Hoff D; Rein RJ; Straits-Tröster K; Thomas RG; McFall MM
Am J Psychiatry; 2003 Feb; 160(2):371-3. PubMed ID: 12562588
[TBL] [Abstract][Full Text] [Related]
12. Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial.
Petrakis IL; Desai N; Gueorguieva R; Arias A; O'Brien E; Jane JS; Sevarino K; Southwick S; Ralevski E
Alcohol Clin Exp Res; 2016 Jan; 40(1):178-86. PubMed ID: 26683790
[TBL] [Abstract][Full Text] [Related]
13. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.
Raskind MA; Peskind ER; Chow B; Harris C; Davis-Karim A; Holmes HA; Hart KL; McFall M; Mellman TA; Reist C; Romesser J; Rosenheck R; Shih MC; Stein MB; Swift R; Gleason T; Lu Y; Huang GD
N Engl J Med; 2018 Feb; 378(6):507-517. PubMed ID: 29414272
[TBL] [Abstract][Full Text] [Related]
14. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder.
Taylor F; Raskind MA
J Clin Psychopharmacol; 2002 Feb; 22(1):82-5. PubMed ID: 11799347
[TBL] [Abstract][Full Text] [Related]
15. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders.
Back SE; McCauley JL; Korte KJ; Gros DF; Leavitt V; Gray KM; Hamner MB; DeSantis SM; Malcolm R; Brady KT; Kalivas PW
J Clin Psychiatry; 2016 Nov; 77(11):e1439-e1446. PubMed ID: 27736051
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study.
Davis LL; Jewell ME; Ambrose S; Farley J; English B; Bartolucci A; Petty F
J Clin Psychopharmacol; 2004 Jun; 24(3):291-7. PubMed ID: 15118483
[TBL] [Abstract][Full Text] [Related]
17. A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.
Simpson TL; Malte CA; Dietel B; Tell D; Pocock I; Lyons R; Varon D; Raskind M; Saxon AJ
Alcohol Clin Exp Res; 2015 May; 39(5):808-17. PubMed ID: 25827659
[TBL] [Abstract][Full Text] [Related]
18. Baclofen treatment for chronic posttraumatic stress disorder.
Drake RG; Davis LL; Cates ME; Jewell ME; Ambrose SM; Lowe JS
Ann Pharmacother; 2003 Sep; 37(9):1177-81. PubMed ID: 12921495
[TBL] [Abstract][Full Text] [Related]
19. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study.
Taylor FB; Martin P; Thompson C; Williams J; Mellman TA; Gross C; Peskind ER; Raskind MA
Biol Psychiatry; 2008 Mar; 63(6):629-32. PubMed ID: 17868655
[TBL] [Abstract][Full Text] [Related]
20. Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.
Villarreal G; Calais LA; Cañive JM; Lundy SL; Pickard J; Toney G
Psychopharmacol Bull; 2007; 40(2):6-18. PubMed ID: 17514183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
